Long-Term Bosentan in Chronic Thromboembolic Pulmonary Hypertension

Publisher： Karger

E-ISSN： 1423-0356|74|3|287-292

ISSN： 0025-7931

Source： Respiration, Vol.74, Iss.3, 2006-05, pp. : 287-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term trial of bosentan monotherapy for pulmonary arterial hypertension in Japanese patients

By Sasayama Shigetake   Satoh Toru   Izumi Tohru   Yoshida Shunji   Kyotani Shingo   Tahara Nobuhiro  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 395-400

Informa Healthcare

Access to resources Recommend Favorite

Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit?

By Clozel Martine  

Annals of Medicine, Vol. 35, Iss. 8, 2003-12 ,pp. : 605-613

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States

By Kirson Noam Y.   Birnbaum Howard G.   Ivanova Jasmina I.   Waldman Tracy   Joish Vijay   Williamson Todd  

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1763-1768

Informa Healthcare

Access to resources Recommend Favorite

Pulmonary endarterectomy as treatment for chronic thromboembolic pulmonary hypertension in sickle cell disease

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 12, 2015-12 ,pp. : E223-E224

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of chronic thromboembolic pulmonary hypertension: current status and emerging options

By Page Aravinda   Ali Jason M   Maraka Jane   Mackenzie-Ross Robert   Jenkins David P  

Clinical Practice, Vol. 10, Iss. 3, 2013-05 ,pp. : 345-357

Future Medicine

Access to resources Recommend Favorite